Piriformis and Gluteal Muscle Thickness in Patients With Unilateral Greater Trochanteric Pain Syndrome

April 8, 2026 updated by: Başak Mansız-Kaplan, Ankara Etlik City Hospital

Observational Assessment of Deep Gluteal Syndrome and Bilateral Piriformis, Gluteus Medius, and Gluteus Maximus Muscle Thickness Using Ultrasonography in Patients With Unilateral Greater Trochanteric Pain Syndrome

This study aims to evaluate muscle thickness in patients with unilateral Greater Trochanteric Pain Syndrome using ultrasonography and to compare these findings with healthy individuals. The primary objective is to determine whether piriformis muscle thickness differs between patients and controls. Secondary objectives include assessing gluteus medius and gluteus maximus muscle thickness, side-to-side differences in piriformis and gluteal muscle thickness, and the presence of Deep Gluteal Syndrome.

Study Overview

Detailed Description

This observational cross-sectional study investigates ultrasonographic muscle morphology and associated clinical findings in patients with unilateral Greater Trochanteric Pain Syndrome (GTPS), focusing on piriformis and gluteal muscle thickness, symptom severity, and Deep Gluteal Syndrome-related findings.

Participants with unilateral GTPS and healthy controls are recruited from outpatient clinical settings. The clinical diagnosis of Greater Trochanteric Pain Syndrome is based on the presence of lateral hip pain in combination with at least two of the following findings: tenderness over the greater trochanter on palpation, pain during a 30-second single-leg stance test, or supportive ultrasonographic findings.

Ultrasonographic evaluations are performed bilaterally to measure piriformis, gluteus medius, and gluteus maximus muscle thickness. For each muscle, three measurements are obtained, and the mean value is used for analysis. Inter-side differences between affected and unaffected hips in the GTPS group and between both hips in the control group are calculated to assess asymmetry.

In the control group, the mean values of both hips are calculated and used as reference values. Comparisons are performed between affected and unaffected hips within the patient group. In addition, muscle thickness of the affected and unaffected hips in the GTPS group is compared separately with the control group mean values for each muscle. Inter-side differences in muscle thickness are also compared between patients and healthy controls. Trochanteric bursal fluid and Doppler signal changes are also evaluated using ultrasonography.

The presence of Deep Gluteal Syndrome is determined based on clinical criteria, defined as at least one clinical finding together with at least two positive standardized clinical provocation tests. Patients are categorized as Deep Gluteal Syndrome-positive or negative accordingly.

Symptom severity is assessed using the VISA-G (Victorian Institute of Sport Assessment-Gluteal) questionnaire. Correlation analyses are performed to evaluate the association between VISA-G scores and inter-side differences in muscle thickness.

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Adults with unilateral Greater Trochanteric Pain Syndrome and healthy individuals without hip pain or known musculoskeletal disorders are being recruited. Participants are evaluated using ultrasonography in an outpatient clinical setting.

Description

Inclusion Criteria:

  • Adults aged 18 years or older
  • Diagnosis of unilateral Greater Trochanteric Pain Syndrome

Exclusion Criteria:

  • Presence of lumbar radiculopathy
  • Presence of hip or spinal osteoarthritis
  • History of lumbar spine or lower extremity surgery
  • Presence of neurological disorders affecting muscles or peripheral nerves
  • Pregnancy
  • Presence of cognitive impairment or neuropsychiatric conditions limiting participation
  • Unwillingness to participate
  • Regular participation in physical exercise (defined as more than two sessions per week)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
GTPS Patients
Patients with unilateral Greater Trochanteric Pain Syndrome evaluated with ultrasonography
Healthy Controls
Healthy individuals without hip pain or known musculoskeletal disorders, evaluated using ultrasonography

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Piriformis Muscle Thickness
Time Frame: At baseline
Comparison of piriformis muscle thickness between patients with unilateral Greater Trochanteric Pain Syndrome and healthy controls using ultrasonography
At baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gluteus Medius and Gluteus Maximus Muscle Thickness
Time Frame: At baseline
Comparison of gluteus medius and gluteus maximus muscle thickness between patients with unilateral Greater Trochanteric Pain Syndrome and healthy controls using ultrasonography.
At baseline
Side-to-Side Muscle Thickness Comparison
Time Frame: At baseline
Within-group comparison of piriformis, gluteus medius, and gluteus maximus muscle thickness between affected and unaffected sides in patients with unilateral Greater Trochanteric Pain Syndrome.
At baseline
Trochanteric Bursa and Doppler Findings
Time Frame: At baseline
Assessment of trochanteric bursal fluid and Doppler signal changes in patients with Greater Trochanteric Pain Syndrome using ultrasonography.
At baseline
Prevalence of Deep Gluteal Syndrome
Time Frame: At baseline
Assessment of the presence of Deep Gluteal Syndrome in patients with Greater Trochanteric Pain Syndrome based on clinical evaluation and standardized provocation tests.
At baseline
Correlation Between VISA-G Score and Hip Muscle Thickness Asymmetry
Time Frame: At baseline
Correlation between VISA-G score and inter-side muscle thickness differences of piriformis, gluteus medius, and gluteus maximus measured by ultrasonography in the patient group.
At baseline
Inter-side difference in muscle thickness between patients and controls
Time Frame: At baseline
Comparison of inter-side differences in piriformis, gluteus medius, and gluteus maximus muscle thickness between patients with unilateral Greater Trochanteric Pain Syndrome and healthy controls using ultrasonography
At baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 2, 2025

Primary Completion (Actual)

March 31, 2026

Study Completion (Actual)

March 31, 2026

Study Registration Dates

First Submitted

March 27, 2026

First Submitted That Met QC Criteria

March 30, 2026

First Posted (Actual)

April 3, 2026

Study Record Updates

Last Update Posted (Actual)

April 13, 2026

Last Update Submitted That Met QC Criteria

April 8, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gluteal Tendinopathy

Subscribe